The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
After finishing at $76.93 in the prior trading day, Colgate-Palmolive Co (NYSE: CL) closed at $77.2, up 0.35%. In other words, the price has increased by $0.35 from its previous closing price. On the day, 8.38 million shares were traded. CL stock price reached its highest trading level at $77.305 during the session, while it also had its lowest trading level at $76.51.
Ratios:
Our goal is to gain a better understanding of CL by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 42.27 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 18.07. For the most recent quarter (mrq), Quick Ratio is recorded 0.60 and its Current Ratio is at 0.93. In the meantime, Its Debt-to-Equity ratio is 9.84 whereas as Long-Term Debt/Eq ratio is at 8.54.
On December 09, 2025, RBC Capital Mkts Upgraded its rating to Outperform which previously was Sector Perform but kept the price unchanged to $88.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 21 ’25 when Massey Sally sold 1,237 shares for $80.89 per share. The transaction valued at 100,061 led to the insider holds 13,751 shares of the business.
Massey Sally sold 2,250 shares of CL for $200,183 on May 15 ’25. The Chief Human Resources Officer now owns 12,583 shares after completing the transaction at $88.97 per share. On Feb 25 ’25, another insider, Massey Sally, who serves as the Chief Human Resources Officer of the company, sold 8,000 shares for $92.02 each. As a result, the insider received 736,152 and left with 14,805 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CL now has a Market Capitalization of 62394642432 and an Enterprise Value of 69557215232. As of this moment, Colgate-Palmolive’s Price-to-Earnings (P/E) ratio for their current fiscal year is 21.63, and their Forward P/E ratio for the next fiscal year is 20.13. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 4.60. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.10 while its Price-to-Book (P/B) ratio in mrq is 72.70. Its current Enterprise Value per Revenue stands at 3.461 whereas that against EBITDA is 14.455.
Stock Price History:
The Beta on a monthly basis for CL is 0.28, which has changed by -0.120397925 over the last 52 weeks, in comparison to a change of 0.16623151 over the same period for the S&P500. Over the past 52 weeks, CL has reached a high of $100.18, while it has fallen to a 52-week low of $74.54. The 50-Day Moving Average of the stock is -1.48%, while the 200-Day Moving Average is calculated to be -9.24%.
Shares Statistics:
The stock has traded on average 6.41M shares per day over the past 3-months and 4735870 shares per day over the last 10 days, according to various share statistics. A total of 806.06M shares are outstanding, with a floating share count of 804.88M. Insiders hold about 0.15% of the company’s shares, while institutions hold 86.01% stake in the company. Shares short for CL as of 1765756800 were 13516071 with a Short Ratio of 2.11, compared to 1763078400 on 14262439. Therefore, it implies a Short% of Shares Outstanding of 13516071 and a Short% of Float of 1.87.
Dividends & Splits
In the trailing 12 months, CL’s forward annual dividend rate was 2.04, compared to 2.06 this year. Against a Trailing Annual Dividend Yield of 0.026517613. The stock’s 5-year Average Dividend Yield is 2.31. The current Payout Ratio is 56.42% for CL, which recently paid a dividend on 2025-10-17 with an ex-dividend date of 2026-01-21. Stock splits for the company last occurred on 2013-05-16 when the company split stock in a 2:1 ratio.
Earnings Estimates
The stock of Colgate-Palmolive Co (CL) is currently drawing attention from 16.0 analysts actively involved in the ongoing evaluation and rating process.The consensus estimate for the next quarter is $0.94, with high estimates of $1.0 and low estimates of $0.9.
Analysts are recommending an EPS of between $3.69 and $3.61 for the fiscal current year, implying an average EPS of $3.65. EPS for the following year is $3.84, with 19.0 analysts recommending between $3.97 and $3.75.
Revenue Estimates
12 analysts predict $5.12B in revenue. The current quarter. It ranges from a high estimate of $5.23B to a low estimate of $5.02B. As of. The current estimate, Colgate-Palmolive Co’s year-ago sales were $4.94BFor the next quarter, 12 analysts are estimating revenue of $5.15B. There is a high estimate of $5.24B for the next quarter, whereas the lowest estimate is $5B.
A total of 18 analysts have provided revenue estimates for CL’s current fiscal year. The highest revenue estimate was $20.43B, while the lowest revenue estimate was $19.98B, resulting in an average revenue estimate of $20.27B. In the same quarter a year ago, actual revenue was $20.1BBased on 18 analysts’ estimates, the company’s revenue will be $20.97B in the next fiscal year. The high estimate is $21.28B and the low estimate is $20.61B.
